FIELD: medicine. SUBSTANCE: method involves intravenously administering radiopharmaceutical preparation containing isotonic solution with alpha-emitter isotope astate-211 into patient organism in the amount of 10-15 ml with specific activity of 1-4 mKi/ml. The treatment course is repeated when needed 30-60 days later. EFFECT: enhanced effectiveness of treatment; lower radiation loading upon patient organism. 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RADIOPHARMACEUTICAL PREPARATION "ASTAT-211" FOR TREATMENT OF ONCOLOGICAL DISEASE OF THYROID | 2001 |
|
RU2191033C1 |
| METHOD OF PRODUCING RADIOPHARMACEUTICAL PREPARATION "ASTATINE-211" | 2015 |
|
RU2593017C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM CHRONIC ARTERIAL INSUFFICIENCY OF LOWER EXTREMITIES | 2000 |
|
RU2162356C1 |
| METHOD FOR PREDICTING PULMONARY ASPHYXIA HEMORRHAGES | 2000 |
|
RU2156109C1 |
| METHOD FOR DIAGNOSIS OF AUTOIMMUNE DISEASES OF THYROID GLAND | 1996 |
|
RU2104531C1 |
| METHOD FOR DETERMINING LEUKOCYTIC ELASTASE ACTIVITY IN PLASMA | 1993 |
|
RU2039983C1 |
| METHOD FOR DETECTING ETHYL ALCOHOL AVAILABILITY IN HUMAN ORGANISM | 2001 |
|
RU2198401C1 |
| METHOD FOR SURGICAL TREATMENT OF THYROID DISEASES | 2004 |
|
RU2257857C1 |
| METHOD OF DIAGNOSING KIDNEY TUMORS | 1994 |
|
RU2085119C1 |
| METHOD FOR STUDYING AND DIAGNOSING PATHOLOGIC CHANGES IN BONE TISSUE IN DIABETES MELLITUS CASES | 2003 |
|
RU2305491C2 |
